期刊文献+

受体相互作用相关蛋白140在正常小鼠脑发育过程中的表达 被引量:4

Expression profile of receptor-interacting protein 140 in the brain:experiment with prenatal and postnatal mice
原文传递
导出
摘要 目的了解受体相互作用相关蛋白(RIP)140在正常小鼠脑发育时期的表达情况。方法应用免疫组化方法研究 RIP140在脑组织中的定位,并应用实时定量 PCR 和 Western 印迹研究RIP140在正常小鼠不同发育时期的动态表达模式。结果免疫组化结果显示 RIP140在正常小鼠脑发育过程中始终存在表达,且在大脑皮质、海马、丘脑等部位有明确的表达。实时定量 PCR 结果显示RIP140 mRNA 在正常小鼠脑不同发育时期的表达呈现动态变化模式,Western 印迹结果示 RIP140蛋白在小鼠脑不同发育时期的表达也呈现动态变化模式,且与 mRNA 的表达具有正相关性(r_s=0.767,P=0.016<双侧>)。结论 RIP140参与了正常小鼠脑发育和脑功能的行使。 Objective To investigate the expression of receptor-interacting protein of 140 000 (RIP140) in the developmental brain. Methods The brain tissues of 15-day-old and 20-day-old fetal Balb/ c mice and 1,7, 14, 28, 42, and 56-day-old postnatal mice were collected. The expression of RIP140 was examined by immunohistochemistry. Real-time PCR and Western blotting were used to quantify the expression of the mRNA and protein levels of RIP140. Results (1) Immunochemistry showed that RIP140 was expressed extensively in the brain of embryonic and newborn mice, mainly present in the neurons in many different brain regions, such as the cerebral cortex, hippocampus and pituitary gland. The cellular location of RIP140 was confined to the nucleus. (2) Real-time PCR revealed that the RIP140 mRNA expression in brain was in an increment as the time went by, peaked on the 7th day after birth, then was in a instable level after that until the adulthood. (3) Western blotting indicated that the protein level of RIP140 was coincident with the mRNA level [ rs = 0.767, P = 0. 016 (bilateral) ]. Conclusion The expression and role of RIP140 may be involved in the whole neurodevelopment stages of brain, and may take part in the development and the function of the brain.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第44期3152-3154,共3页 National Medical Journal of China
基金 国家重大基础研究发展规划基金(2001CB510303)
关键词 唐氏综合征 聚合酶链反应 RIP140 Down syndrome Polymerase chain reaction RIP140
  • 相关文献

参考文献7

  • 1Gardiner K. Transcriptional dysregulation in Down syndrome: predictions for altered protein complex stoichiometries and posttranslational modifications, and consequences for learning/ behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behav Genet,2006 ,36 :439-453.
  • 2Cavailles V, Dauvois S, L'Horset F, et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J,1995, 14:3741-3751.
  • 3Klinge CM, Carolyn M. Estrogen receptor interaction with coactivators and co-repressors. Steroids,2000, 65:505-512.
  • 4Chan S, Kilby MD. Thyroid hormone and central nervous system development. J Endocrino1,2000,165 : 1-8.
  • 5Morgane PJ, Austin-LaFrance R, Bronzino J, et al. Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev, 1993,17 : 91-128.
  • 6Lee CH, Wei LN. Characterization of receptor-interacting protein 140 in retinoid receptor activities. J Biol Chem, 1999, 274: 31320-31326.
  • 7Powelka AM, Seth A, Virbasius JV, et al. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional eorepressor RIP140 in mouse adipocytes. J Clin Invest, 2006, 116 : 125-136.

同被引文献44

  • 1Bahn S, Mimmack M, Ryan M, et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet, 2002, 359:310-315.
  • 2Treuter E, Albrektsen T, Johansson L, et al. A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol, 1998, 12: 864-881.
  • 3Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging, 2005, 26: 349-354.
  • 4Livak KJ,Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△Ct method. Methods, 2001,25:402-208.
  • 5Klinge CM, Carolyn M. Estrogen receptor interaction with coactivators and co-repressors. Steroids, 2000, 65 : 227-251.
  • 6Chan S, Kilby MD. Thyroid hormone and central nervous system development. J Endocrinol, 2000, 165:1-8.
  • 7Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res, 2005, 81: 302-313.
  • 8Mann DM, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci, 1989, 89: 169-179.
  • 9Mann DM, Iwatsubo T, Fukumoto H, et al. Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques. Acta Neuropathol, 1995, 90 : 472-477.
  • 10Cohon CA, Yao J, Taffs RE, et al. Abnormal production of interleukin-1 by microglia from trisomy 16 mice. Neurosci Lett, 1991, 132: 270-274.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部